Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00151788 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.
A Phase 2 study, sponsored by Daiichi Sankyo.
- Terminated
- Registry status
- Phase 2
- Development phase
- 796
- Enrollment target
NCT00151788: Clinical Trial Phase 2 study, sponsored by Daiichi Sankyo.
NCT00151788 is a Phase 2 study that was terminated before completion, run by Daiichi Sankyo. The registered enrollment target is 796 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (498% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00151788, a Phase 2 study, was terminated before completion, sponsored by Daiichi Sankyo.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 796 participants
- Enrollment target
Study Summary
The effects of pactimibe versus placebo on the progression of atherosclerosis in the carotid arteries will be assessed using standard ultrasound techniques.
Interventions
- DRUG Pactimibe sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 796 participants |
| Start Date | 2004-02 |
| Est. Completion | 2006-03 |
| Phase | Phase 2 |
Why NCT00151788 stopped before completion
NCT00151788 is an interventional study that assigns participants to a tested intervention. The registered 796 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (498% higher).
The record links to 0 conditions, and to 1 intervention - of which Pactimibe sulfate is the first listed.
NCT00151788 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00151788 about?
NCT00151788 is a clinical study titled "Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.". The effects of pactimibe versus placebo on the progression of atherosclerosis in the carotid arteries will be assessed using standard ultrasound techniques.
What is the current status of trial NCT00151788?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 796 participants. The study started on 2004-02. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00151788?
The interventions under investigation include: Pactimibe sulfate (DRUG).
Who is sponsoring clinical trial NCT00151788?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00151788's enrollment target sits among peer trials
796 40th of 2000 higher than 1,961 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05150691 · 796 participants · Phase 1
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- NCT06208150 · 795 participants · Phase 3
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
- NCT06724172 · 795 participants · NA
CHIME: Comparing Health Interventions for Maternal Equity
- NCT06051058 · 798 participants · NA
Care Transitions App for Patients With Multiple Chronic Conditions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia